Title : Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1.

Pub. Date : 2011 Mar 19

PMID : 21418583






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens
2 MG132 in combination with resveratrol caused cell cycle blockade at G1/S transition via p27Kip1 accumulation. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens
3 Knockdown of p27Kip1 using siRNA dramatically attenuated the protective effects of resveratrol on cytotoxic actions of proteasome inhibitors against leukemic cells. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens
4 MG132 in combination with resveratrol caused synergistic induction of p27Kip1 through increased recruitment of FOXO1 on the p27Kip1 promoter. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens
5 MG132 in combination with resveratrol caused synergistic induction of p27Kip1 through increased recruitment of FOXO1 on the p27Kip1 promoter. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens
6 CONCLUSIONS: Resveratrol may have the potential to negate the cytotoxic effects of proteasome inhibitors via regulation of FOXO1 transcriptional activity and accumulation of p27Kip1. Resveratrol cyclin dependent kinase inhibitor 1B Homo sapiens